Neumora Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Neumora Therapeutics Inc
TickerNMRA
CIK #0001885522
CUSIP640979100
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address490 Arsenal Way, Suite 200, Watertown, MA 02472
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Neumora Therapeutics Inc 2023-01-03 474.4 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001885522] 10-K
[0001885522] 10-Q
[0001885522] 3
[0001885522] 4
[0001885522] 8-K
[0001885522] D
[0001885522] SC 13D
[0001885522] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Invus Global Management LLC Neumora Therapeutics Inc [2026-02-19] 0.0
K2 Healthventures Equity Trust LLC Neumora Therapeutics Inc [2025-08-11] 0.0
Softbank Group Corp Neumora Therapeutics Inc [2024-11-12] 4.7
FMR LLC Neumora Therapeutics Inc [2024-07-08] 0.0
FMR LLC Neumora Therapeutics Inc [2024-07-08] 0.0
Berns Paul L Neumora Therapeutics Inc [2024-02-14] 5.2
Softbank Group Corp Neumora Therapeutics Inc [2024-02-13] 5.0
Arch Venture Fund XII LP Neumora Therapeutics Inc [2023-10-02] 19.6
Amgen Inc Neumora Therapeutics Inc [2023-09-27] 819423.2
Form 3/4/5 Filer 2011 - 2026
Neumora Therapeutics Inc
Burow Kristina
Piacquad David
Ho Maykin
Halawa Alaa
Fust Matthew K
Aurora Daljit Singh
Milligan Michael Lee
Berns Paul L
Pinto Joshua
Duncan Jason
Arch Venture Partners X LLC
Arch Venture Partners VIII LLC
Arch Venture Fund X Overage LP
Arch Venture Partners X LP
Arch Venture Fund X LP
Arch Venture Fund VII LP
Arch Venture Fund VIII Overage LP
Arch Venture Partners X Overage LP
Arch Venture Partners VII LP
Arch Venture Partners VII LLC
Arch Venture Fund XII LP
Arch Venture Partners XII LLC
Bybee Clinton
Nelsen Robert
Gillis Steven
Crandell Keith
Arch Venture Partners XII LP
Lenz Robert A
Suh Carol Y
Gosebruch Henry O
FMR LLC
Amgen Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Aurora Daljit Singh
Common Stock
2026-02-17 Sell 6,165 $3.56 21,947
Berns Paul L
Common Stock
2026-02-17 Sell 9,819 $3.51 34,465
Milligan Michael Lee
Common Stock
2026-02-17 Sell 1,436 $3.57 5,127
Pinto Joshua
Common Stock
2026-02-17 Sell 5,967 $3.54 21,123
Aurora Daljit Singh
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 750,000 $0.00
Duncan Jason
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 750,000 $0.00
Pinto Joshua
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 1,200,000 $0.00
Berns Paul L
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 1,650,000 $0.00
Milligan Michael Lee
Stock Option (Right to Buy) · derivative
2026-01-08 Grant 350,000 $0.00
Aurora Daljit Singh
Common Stock
2025-11-11 Sell 114,703 $2.68 307,404
Burow Kristina
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Arch Venture Fund XII LP +6
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Arch Venture Partners X LLC +9
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Ho Maykin
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 95,586
Milligan Michael Lee
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 85,391
Milligan Michael Lee
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 38,234
Milligan Michael Lee
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 28,675
Milligan Michael Lee
Stock Option (Right to Buy) · derivative
2025-05-28 Disposed to issuer 41,250
Milligan Michael Lee
Stock Option (Right to Buy) · derivative
2025-05-28 Grant 400,000
Milligan Michael Lee
Stock Option (Right to Buy) · derivative
2025-05-28 Grant 85,391
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 114 72,248,874
2025-12-31 102 63,208,352
2025-09-30 96 49,134,336
2025-06-30 100 54,090,100
2025-03-31 119 63,438,763
2024-12-31 147 86,392,411
2024-09-30 109 64,615,597
2024-06-30 95 67,028,203
2024-03-31 89 48,769,474
2023-12-31 61 43,872,484
2023-09-30 39 44,000,083
Form 13F Holdings
Firm Period DFND Voting Shares
Wellcome Trust Ltd the as Trustee of the Wellcome Trust [2026-06-30] SOLE 3,309,123 3,309,123
Addis & Hill Incorporated [2026-06-30] SOLE 0 163,386
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 1,320
Capital Advisors Ltd LLC [2026-06-30] SOLE 0 145
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com